|
Feb 19, 2021
|
Initial S-1
|
|
May 7, 2021
|
Amended S-1
Sign In
to view filing content.
|
|
May 25, 2021
|
Amended S-1
Sign In
to view filing content.
|
|
May 28, 2021
|
Amended S-1
Sign In
to view filing content.
|
|
Jun 11, 2021
|
Amended S-1
Sign In
to view filing content.
|
|
Jul 1, 2021
|
Amended S-1
Sign In
to view filing content.
|
|
Jul 14, 2021
|
PR announcing pricing of $40mm IPO
Sign In
to view filing content.
|
|
Jul 19, 2021
|
424B4 IPO Prospectus
|
|
Jul 21, 2021
|
PR announcing partial over-allotment exercise
Sign In
to view filing content.
|
|
Sep 3, 2021
|
8-K announcing separate trading of common stock and warrants
Sign In
to view filing content.
|
|
Oct 3, 2022
|
8-K announcing business combination with Estrella Biopharma, Inc.
Sign In
to view filing content.
|
|
Oct 11, 2022
|
8-K announcing change in certifying accountant
Sign In
to view filing content.
|
|
Oct 18, 2022
|
S-4 Registration Statement and Preliminary Proxy for shareholder meeting to approve merger with Estrella Biopharma, Inc.
Sign In
to view filing content.
|
|
Nov 25, 2022
|
PRE14A Preliminary Proxy for charter extension meeting
Sign In
to view filing content.
|
|
Dec 6, 2022
|
DEF14A Definitive proxy for charter extension meeting
Sign In
to view filing content.
|
|
Dec 19, 2022
|
S-4/A Amendment #1 to registration statement containing preliminary proxy for Estrella Biopharma, Inc. business combination
Sign In
to view filing content.
|
|
Dec 29, 2022
|
8-K with extension meeting results
Sign In
to view filing content.
|
|
Jan 5, 2023
|
8-K with redemption statistics for charter extension meeting
Sign In
to view filing content.
|
|
Jan 24, 2023
|
8-K announcing sponsor contribution to trust in connection with extension
Sign In
to view filing content.
|
|
Feb 3, 2023
|
S-4/A Amendment #2 to registration statement containing preliminary proxy for Estrella Biopharma, Inc. business combination
Sign In
to view filing content.
|
|
Feb 21, 2023
|
8-K announcing sponsor contribution to trust in connection with extension
Sign In
to view filing content.
|
|
Mar 8, 2023
|
425 with update on intended merger target - Estrella Biopharma, Inc.
Sign In
to view filing content.
|
|
Mar 20, 2023
|
8-K announcing sponsor contribution to trust in connection with extension
Sign In
to view filing content.
|
|
Apr 13, 2023
|
8-K announcing sponsor contribution to trust in connection with extension
Sign In
to view filing content.
|
|
Apr 24, 2023
|
8-K announcing common stock purchase agreement
Sign In
to view filing content.
|
|
Apr 26, 2023
|
8-K with amendment to common stock purchase agreement
Sign In
to view filing content.
|
|
May 2, 2023
|
S-4/A Amendment #3 to registration statement containing preliminary proxy for Estrella Biopharma, Inc. business combination
Sign In
to view filing content.
|
|
May 19, 2023
|
8-K announcing sponsor contribution to trust in connection with extension
Sign In
to view filing content.
|
|
May 25, 2023
|
PRE14A Preliminary Proxy for charter extension meeting
Sign In
to view filing content.
|
|
Jun 16, 2023
|
S-4/A Amendment #4 to registration statement containing preliminary proxy for Estrella Biopharma, Inc. business combination
Sign In
to view filing content.
|
|
Jun 16, 2023
|
DEF14A Definitive Proxy for charter extension meeting
Sign In
to view filing content.
|
|
Jun 20, 2023
|
8-K announcing sponsor contribution to trust in connection with extension
Sign In
to view filing content.
|
|
Jun 30, 2023
|
S-4/A Amendment #5 to registration statement containing preliminary proxy for Estrella Biopharma, Inc. business combination
Sign In
to view filing content.
|
|
Jul 7, 2023
|
S-4/A Amendment #6 to registration statement containing preliminary proxy for Estrella Biopharma, Inc. business combination
Sign In
to view filing content.
|
|
Jul 10, 2023
|
S-4/A Amendment #7 to registration statement containing preliminary proxy for Estrella Biopharma, Inc. business combination
|
|
Jul 11, 2023
|
424B3 containing definitive proxy for Estrella Biopharma business combination
Sign In
to view filing content.
|
|
Jul 12, 2023
|
8-K announcing trust account held in cash and updated estimated redemption price for charter extension meeting
Sign In
to view filing content.
|
|
Jul 18, 2023
|
PR announcing sponsor contribution to trust in connection with extension
Sign In
to view filing content.
|
|
Jul 19, 2023
|
8-K with extension meeting results
Sign In
to view filing content.
|
|
Jul 19, 2023
|
8-K confirming funding of extension payment
Sign In
to view filing content.
|
|
Jul 26, 2023
|
8-K announcing Binding PIPE Investment Term Sheet
Sign In
to view filing content.
|
|
Aug 1, 2023
|
8-K with Estrella Biopharma meeting results
Sign In
to view filing content.
|
|
Aug 18, 2023
|
8-K confirming funding of extension payment
Sign In
to view filing content.
|
|
Sep 18, 2023
|
8-K confirming funding of extension payment
Sign In
to view filing content.
|
|
Sep 20, 2023
|
8-K announcing $10mm PIPE
Sign In
to view filing content.
|
|
Sep 29, 2023
|
CA Corporate Action Alert announcing closing of Estrella Biopharma business combination
Sign In
to view filing content.
|
|
Oct 5, 2023
|
Super 8-K for closing of Estrella Biopharma business combination
Sign In
to view filing content.
|
|
Oct 11, 2023
|
S-1 Post-closing registration statement
Sign In
to view filing content.
|
|
Nov 13, 2023
|
S-1/A Amendment to post-closing registration statement
Sign In
to view filing content.
|
|
Dec 18, 2023
|
S-1/A Amendment to post-closing registration statement
Sign In
to view filing content.
|
|
Dec 28, 2023
|
EFFECT Effectiveness of post-closing registration statement
Sign In
to view filing content.
|